InnovAge Posts Strong Q2 Earnings, Raises Full-Year Outlook on Operational Gains
InnovAge (INNV) reported robust fiscal Q2 2026 results, with revenue and adjusted EBITDA showing significant year-over-year growth. The PACE provider raised its full-year guidance, citing improved revenue integrity, medical cost management, and better-than-expected Medicaid reinstatements.